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Abstract
Background: Extensive information on cervical cancer is currently available. Its effectiveness in reducing anxiety in
women receiving abnormal Pap tests is not clear. We investigated current practices of communicating abnormal
Pap results to evaluate women’s reactions and determine the sources of information they use subsequently.
Methods: A self-administered questionnaire-based study was performed in 1475 women in France, Spain and
Portugal who had received an abnormal Pap smear result in the 12 months prior to completing the questionnaire.
Questions covered methods of communication of the result, emotional reactions, support received (from the
physician and entourage), and information sources, using pre-specified check box options and rating scales. Data
were analyzed by country.
Results: Pap test results were mostly communicated by phone to Spanish women (76%), while physician letters
were common in France (59%) and Portugal (36%). Frequent reactions were anxiety, panic and stress, which were
less common in Spanish women than their French and Portuguese counterparts. After discussing with their
physician, half of the participants were worried, despite rating highly the psychological support received. Over 90%
of women in each country discussed their results with family or friends. Partners provided a high level of support.
Overall, the abnormal diagnosis and consequences had a low to medium impact on daily, professional and family
life and their relationships with their partner. Impact was higher in Spanish women than the French or Portuguese.
Information on the diagnosis and its treatment was rated average, and nearly 80% of participants wanted more
information, notably French women. Preferred sources were the physician and the Internet.
Conclusions: Women expressed a strong wish for more information about cervical cancer and other HPV-related
diseases, and that their physician play a major role in its provision and in support. There was a heavy reliance on
the close entourage and the Internet for information, highlighting the need for dissemination of accurate material.
Differences between countries suggest information management strategies may need to be tailored to different
geographical regions.
Background
Cervical cancer is the second most common cancer in
women affecting nearly 530 000 females worldwide and
resulting in 275 000 deaths each year, including 31 000
cases and 13 000 deaths in Europe [1]. Human papillo-
mavirus (HPV) infection can lead to the development of
pre-cancerous lesions and cervical cancer [2]. Routine
screening and HPV vaccination programs have increased
the visibility of cervical cancer in the wider community,
and may contribute to increasing concerns about devel-
oping this cancer, particularly in younger women [3].
Studies report that after being informed of an abnor-
mal Pap smear test result, women commonly feel
stressed and anxious [4-6], irrespective of the severity of
the result [7]. These emotions are often long lasting,
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Lack of accurate understandable medical information
about the causes, prevention, treatment and conse-
quences of an abnormal Pap smear result and cervical
cancer leads to anxiety [9]. A study in the UK reported
that the method and content of information communi-
cated to patients receiving an abnormal smear varied
widely, emphasizing the need for a uniform approach
[10].
The introduction of national HPV vaccination pro-
grams and cancer screening campaigns in Europe has
been highly publicized. Providing appropriate and accu-
rate information is an important element in the success-
ful management of cervical cancer screening. A study of
over 1000 Irish women provided evidence of the nega-
tive impact of poor knowledge about Pap testing on
screening attendance. False perceptions, including that
the test is time consuming and that women having a
test were at a higher risk of cervical cancer than those
not having it, were barriers to women attending a rou-
tine screen [11]. Data on patient perception of abnormal
Pap testing results subsequent to the implementation of
these programs are limited, although a recent UK study
described a need for better delivery and content of cer-
vical screening result notifications and suggested that
both screening centres and clinics need to review their
practices [12].
Improving knowledge about cervical cancer in the
wider community should contribute to reducing anxiety
on receipt of an abnormal test. We performed a large
q u e s t i o n n a i r es u r v e yi nE u r o p et oa s s e s s“real life”
experiences among women receiving an abnormal Pap
smear test. We wished to identify patient’s reactions to
being informed, how well informed and supported they
felt, and how they obtained information about their test
result. Data were collected in relation to communication
of results, women’s reactions, support received, informa-
tion about the potential consequences, as well as the
impact this news had on their daily lives. This informa-
tion can be used to improve communication and infor-
mation practices.
Methods
Study design
We conducted a retrospective, cross-sectional, question-
naire-based study in which women were recruited from
a total of 40 medical centres and gynaecological prac-
tices in France, Spain and Portugal between March and
July 2008. The questionnaire was also distributed in
Italy however data were incomplete and are not pre-
sented. The survey was implemented by the French
Women Against Cervical Cancer (WACC) Foundation
as part of a national education program on cervical can-
cer screening. Participating gynaecologists were selected
by the WACC Foundation. The questionnaire was dis-
tributed to women consulting their physician for a rou-
tine visit or due to receipt of an abnormal test result
following routine screening. Potential participants were
given the questionnaire at the clinic reception on arrival
for their consultation, and it was completed prior to
their appointment. Women were free to refuse to com-
plete the questionnaire. Ethics committee approval was
not required for the study given that no clinical proce-
dures were performed and patient records were not
used.
Participants
Potential participants were identified by the physician on
the basis of a previous abnormal Pap result. Women
consulting the gynaecologist for a routine visit or due to
receipt of an abnormal test result following routine
screening and who had received at least one abnormal
Pap smear result (atypical squamous cells of undeter-
mined significance [ASCUS] or more severe) during the
previous 12 months were eligible to participate. Patients
considered to have inadequate language skills or an
intellectual disability were excluded. No other criteria
were used.
Questionnaire
The self-administered questionnaire was developed in
English by a WACC Foundation task force on the basis
of a literature review, and was translated into local lan-
guages. The questionnaire was validated by a country
coordinator from each participating country in conjunc-
tion with an expert responsible for the methodology and
analyses. Paper copies were completed with a pen in the
waiting room prior to the consultation. An introductory
paragraph explained to the participant why the WACC
was performing the study and invited them to answer a
series of questions (see Additional File 1: WACC Ques-
tionnaire). In brief, the questionnaire was composed of
15 questions covering basic demography and Pap test
results, how participants were told about the abnormal
Pap test result, how they felt when they were told, how
they felt about the support they received from medical
and personal networks, what treatment they had and
how they obtained information about the result. Eleven
of the questions had pre-specified check box response
options and where appropriate, had a free-text option
for ‘other’. Responses to the question about diagnosis
were cross-checked with the patient’s medical dossier.
Patients who did not know what diagnosis they had
were not included. The number of answers allowed per
question was specified. For the four questions regarding
the psychological support received, impact on daily life,
and how well informed they considered themselves to
be, participants were asked to rank their response on a
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ber; one was the least supported, informed or impacted
while ten was completely supported, informed or
impacted.
Analysis
Data were entered in a central database and analyzed
globally and by country. Descriptive statistics were used
to describe all data. Results are presented by question
using an abbreviated description. For questions with
pre-specified response options, frequency by patient is
presented according to pre-specified options. For ques-
tions with a rating scale, mean scores are presented with
standard deviations. The corresponding survey question
(see Additional File 1: WACC Questionnaire) is indi-
cated in the text or table. The study was not designed
for formal statistical analysis and data were thus
reviewed for broad trends in current practices which
may be used to identify areas for improvement. Student
t-tests were performed to determine statistically signifi-
cant differences between countries. Missing data were
reported for between 2% and 18% of responses, depend-
ing on the question.
Results
A total of 1475 women (765 in France, 467 in Spain and
243 in Portugal) with abnormal Pap smear results
agreed to participate in the study. Demographic charac-
teristics, summarised in Table 1, were similar between
the three countries. The majority of participants (87%)
were less than 50 years old. French and Spanish partici-
pants were younger compared to those from Portugal
(35%, 29%, and 16% were younger than 30 years old,
respectively). Just over half (55%) of the patients were
married or living with their partner, and most (at least
61%) had at least one child. More French women were
childless compared to women in Spain and Portugal
(31%, 10% and 8%, respectively).
Communication of test results, follow-up, and feelings
experienced
Method of communication of test results
Results of an abnormal Pap test were most commonly
communicated to the participant via a telephone call
(from the physician or the physician’s secretary) to
arrange an appointment to discuss the results (24% and
28% respectively, Table 2). Twenty-two percent of
patients received a letter from the physician asking
them to make an appointment. In some cases (14%),
laboratory results were sent directly with a note from
the physician. Results were different between countries;
in Spain, approximately three-quarters of participants
received the news over the phone, notably via the physi-
cian’s secretary, while letters were rarely sent. In
contrast, approximately 60% of French women and 40%
of Portuguese patients were told via a letter.
Feelings experienced upon being informed and support
received
Overall, anxiety, panic and stress were the most frequent
initial reactions (59%, 33% and 23% respectively; Table
2). Anger and guilt were reported in less than 10% of
participants. Fewer Spanish women said they felt
anxious (36%, versus 74% and 67% in France and Portu-
gal respectively) or were stressed by the test results (8%
compared to 39% of French women and 24% of Portu-
guese women). One in four women said they did not
understand what the abnormal result meant and that
they needed information, notably in France and Spain
(25% and 30% respectively).
After having discussed the test results and follow-up
treatment with their gynaecologist, approximately half of
the patients remained worried, although a third said
they felt reassured and nearly 20% felt confident (Table
2). Little variation was reported between countries in
reactions to the physician’s explanation of their results.
Patients felt that they had received reasonable psycho-
logical support from their gynaecologist in relation to
being informed about the initial test results (Question
6), with a mean score of 7.3 (± 2.8) out of 10.
Table 1 Demographic characteristics of study participants
% patients
Total
(N = 1475)
France
(N = 765)
A
Spain
(N = 467)
B
Portugal
(N = 243)
C
Age (years)
<30 26.6 34.9
C* 28.6
C 16.3
30 to 39 37.9 35.9 35.7 42.2
40 to 49 22.3 19.1 23.8 23.9
50 to 59 8.9 7.6 7.5 11.7
≥60 2.7 2.2 1.5 4.2
Missing data 1.6 0.3 2.9
A 1.7
Marital status
Married/living
with partner
55.2 57.6 50 59.3
Single 32.3 33.3
C 38.2
C 24.1
Divorced 10.3 8.3 10.3 12.5
Widowed 2.2 0.8 1.5 4.1
A
Number of children
0 16.4 30.7
C 10.4
C 8.4
1 26.1 22.5 22.1 33.3
2 23.5 16.6 23.1 30.9
A
>2 11.4 9.7 12.0 12.6
Missing data 22.6 20.5 32.4
AC 14.8
Data from Question 1
Superscript letters (A, B, C) show significant superiority (0.1% risk; student t-
test) relative to the corresponding value in the superscript column indicated.
*eg, the 34.9% rate of patients under 30 years in France (column A) was
significantly greater than the 16.3% rate in Portugal (column C).
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apparent; 8.1 (± 2.2) in Portugal, 7.6 (± 2.8) in Spain
and 6.2 (± 2.8) in France. In all three countries, the
majority of women (93%) discussed their results with
someone else (Question 7), notably their partner (69%),
a friend (40%) or their mother (37%). The mean score
for level of support received from a partner (Question
11) was 7.3 (± 3.1) out of 10, and was similar across
countries, being 8.0 (± 2.7) in Portugal, 7.8 (± 2.9) in
Spain and 6.8 (± 3.2) in France.
Impact on quality of life
Participants were asked to evaluate the impact of their
illness (abnormal diagnosis and its consequences) on
various aspects of their lives (Table 3). Overall, women
rated the impact as being relatively low in all areas
investigated; mean scores were 4.0 (± 3.0) in terms of
their relationship with their partner, 3.4 (± 2.7) for daily
life, 3.0 (± 2.5) for family life and 2.6 (± 2.4) for profes-
sional life. Portuguese women considered the diagnosis
had a greater impact on their family and professional
life compared to Spanish women (for family life, mean
scores were 3.8 in Portugal compared to 2.6 in France
and Spain; for professional life, mean scores were 3.1
compared to 2.5 and 2.4 in France and Spain,
respectively).
Information about the diagnosis and treatments
Diagnosis and treatment management
Diagnoses were mainly CIN1, 2/3, were not considered
serious or were not in need of monitoring (approxi-
mately 25% each; Table 4). CIN1 or 2/3 diagnoses were
at least twice as common in the Spanish and Portuguese
participants than in the French women (70%, 59% versus
33% respectively), the latter having a higher rate of non-
serious diagnoses (35%). The most common follow-up
procedures prescribed were colposcopy, biopsy, 6-month
cervical smear check-up or cervical conisation (50%,
42%, 32% and 30% respectively). Colposcopy was more
common in France than Spain or Portugal, while check-
up smears were prescribed more frequently in Spain.
Approximately half of the participants were worried
about the treatment plan proposed, compared to one-
third who were reassured. Feelings evoked were similar
across all three countries.
Feelings about communication of information
Overall, in terms of being informed about their disease
and treatments, mean scores were mid-range, being 5.9
(± 3.2) and 5.9 (± 3.3) respectively (Table 5). Scores
were lower in France (4.8 ± 3.0 and 4.6 ± 3.0, respec-
tively), compared with Spain (6.2 ± 3.4 and 6.1 ± 3.4,
respectively) and Portugal (7.0 ± 2.8 and 7.0 ± 2.0,
respectively). Women were also asked how well
informed they felt about the consequences (emotional,
on their relationship with their partner, family life and
future motherhood) of their illness. Mean scores were
Table 2 Communication of abnormal Pap test results,
reaction to it (in at least 10% of patients in any one
country) and follow-up of abnormal Pap smear results
% patients
Total
(N = 1475)
France
(N = 765)
A
Spain
(N = 467)
B
Portugal
(N = 243)
C
Announcement made via:
Letter 36.0 58.9
BC 12.7 36.3
B
From physician 22.1 33.6
B 9.2 23.5
B
From laboratory ±
physician
13.9 25.3
BC 3.5 12.8
B
Phone call 52.0 31.9 75.7
AC 48.4
A
From physician’s
secretary
27.8 8.5 53.4
AC 21.5
A
From physician 24.2 23.4 22.3 26.9
Other 13.7 10.6 14.0 16.6
Initial feelings after being told of abnormal Pap smear test result*
Anxiety 59.1 74.0
B 36.4 66.9
B
Panic 32.9 29.1 25.6 43.9
AB
Stress 23.3 38.6
BC 7.6 23.9
B
Did not know
what it meant
22.9 25.1 29.9
C 13.8
Incredulity 9.9 4.5 17.8
AC 7.5
Guilty 8.6 8.4 11.9
C 5.4
Anger 8.4 7.6
C 15.6
AC 2.0
Feelings after physician’s explanation of findings and next steps*
Worried 51.5 47.3 56.0
A 51.2
Reassured 33.9 34.5 30.7 36.4
Confident 19.2 19.3
C 7.3 31.0
AB
Optimistic 17.7 9.8
BC 19.9 23.5
Relieved 14.5 11.6 14.9 16.9
Disorientated 13.7 18.5
BC 12.5 9.9
Depressed 11.8 15.7C 13.0
C 6.6
Data from Questions 3, 4 and 5
Superscript letters (A, B, C) show significantly superiority (0.1% risk; Student t-
test) relative to the corresponding value in the superscript column indicated.
*Up to three responses per question permitted
Table 3 Impact of illness on aspects of life
Mean score (±SD)*
Total
(N = 1475)
France
(N = 765)
A
Spain
(N = 467)
B
Portugal
(N = 243)
C
Has the illness had any impact on...?
Family life 3.0 (2.5) 2.6 (2.4) 2.6 (2.5) 3.8 (2.7)
AB
Professional life 2.6 (2.4) 2.5 (2.3) 2.4 (2.5) 3.1 (2.5)
Daily life 3.4 (2.7) 3.4 (2.7) 3.1 (2.7) 3.6 (2.6)
Relationship with
partner
4.0 (3.0) 4.0 (2.9) 3.9 (3.1) 4.1 (2.9)
Data from Question 10
Superscript letters (A, B, C) show significantly superiority (0.1% risk; student t-
test) relative to the corresponding value in the superscript column indicated.
*Scale from 1 to 10, where 1 is no effect and 10 is severely affected.
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French women consistently reported feeling less well-
informed than Spanish or Portuguese women in all
areas.
Source of information
All women considered their gynaecologist to be the main
source of information on the disease and its consequences
(80%; Table 5). Internet was also important, being used by
38% of participants, notably in France (46%, versus 35% in
Portugal and 34% in Spain), along with the media (televi-
sion, radio, newspapers). Fewer French women obtained
information from their physician than Spanish and Portu-
guese women. Friends and the media had a similar but
low ranking as information sources (14% and 15% respec-
tively). Participants had a preference for their physician
and the Internet as information sources (79% and 41%,
respectively), as well as newsletters and media (24% and
20% respectively; Table 5). When asked if they would like
to receive more information on cervical cancer and other
HPV-linked genital diseases and their prevention (Ques-
tion 14), almost 80% of the women (76% France, 82%
Spain and 82% Portugal) interviewed said they “absolutely”
wanted more information.
Discussion
Despite increasing public awareness of HPV and cervical
cancer, the results from our survey of nearly 1500 women
in France, Spain and Portugal show that the current profile
of feelings (predominantly anxiety, panic and stress) in
response to being informed of an abnormal Pap result cor-
responds with earlier published results [4-6]. Initial reac-
tions of anxiety may be fueled by how this news is
communicated. In our survey, test results were mainly
communicated over the phone in Spain, while in Portugal
and particularly in France, letters were more common. It
has been reported that women receiving a diagnosis of
CIN1, 2 or 3 over the phone wanted more information
and the opportunity to discuss their results in a more per-
sonal way [13]. A recent report from Sweden suggested
that the wording in a letter plays an important role in the
level of anxiety felt by women referred for a colposcopy
after an abnormal cervical smear [14].
Being well informed is critical for lowering anxiety over
abnormal results. Concern in HPV-positive women wait-
ing for a second HPV test was alleviated if their informa-
tion needs were met [15]. In our study, approximately a
quarter of the women did not understand what the test
results meant and nearly 80% stated a wish for more
information. The level of information provided was
ranked as average, notably in terms of the consequences
on their lives, emotions and family. Over half of the parti-
cipants in our study remained worried following a discus-
sion with their physician about what their test results
meant. Furthermore, results from a study by Pirotta et al.
[16] suggest that even when patients are well-informed
they are not necessarily less anxious. This reinforces the
need for continual reassurance and follow-up from their
physician. While the majority of participants in our study
reported favourably on the psychological support they
received from their physician, an Australian study has
shown that women wish to participate in decisions about
their care but find it hard to ask questions [17]. Physi-
cians should bear in mind that patients may not sponta-
neously request further information, despite (or perhaps
because of) high levels of anxiety [9].
Our study highlights that in the current environment
of easy access to information via the Internet, physicians
are nonetheless considered the primary information pro-
vider. Furthermore, participants in all three countries
Table 4 Test results, participants’ feelings towards
treatment and impact on life
% patients
Total
(N = 1475)
France
(N = 765)
A
Spain
(N = 467)
B
Portugal
(N = 243)
C
Abnormal test result
CIN1 28.4 16.6 39.7
A 28.9
A
CIN2/3 25.4 16.2 29.8
A 30.2
A
Not serious/to be
monitored
24.8 34.6
BC 16.2 23.7
Cervical cancer 4.7 2.6 3.3 8.2
A
Other 14.4 22.8
BC 13.2 7.3
Disease management*
Colposcopy 49.5 70.7
BC 35.6 42.1
Biopsy 42.0 32.1 44.4
A 49.6
A
Check-up smear in
6 months
31.6 26.2 44.2
AC 24.4
Cervical conisation 30.0 20.0 38.0
A 31.8
A
HPV test 22.7 22.4 29.5
AC 16.1
Check-up smear in
1 year
9.7 8.9 11.7 8.7
Other 9.3 8.9 8.6 10.3
Hysterectomy 2.1 0.8 2.6
A 2.9
Don’t know 3.1 3.4 2.2 3.7
Feelings about treatment or wait**
Worried 55.9 50.0 53.9 63.9
A
Confident
(reassured)
33.8 31.3 34.2 35.7
Physical integrity
under threat
15.7 21.8
BC 14.7 10.5
Depressed 10.9 10.4 10.5 11.8
Disorientated 12.0 16.7
C 13.4
C 5.9
Ashamed 2.1 3.2 2.2 0.8
Alone 5.5 10.9
BC 4.4 1.3
Data from Questions 2, 8, 9
Superscript letters (A, B, C) show significantly superiority (0.1% risk) relative to
the corresponding value in the indicated superscript column.
*More than one response possible
**Up to three responses per question
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centage of women said they also discussed their test
results with their partners, friends or mothers should be
taken into consideration. This emphasizes the impor-
tance of the general public being well informed about
cervical cancer and precancerous diagnoses.
The method and content of the information commu-
nicated should be carefully considered. One study
showed that women had a significantly higher level of
satisfaction with visual teaching aids (graphic and video)
compared with verbal communication [18]. Information
sheets and verbal presentations about treatment, includ-
ing details of procedures and long-term effects are help-
ful for reducing anxiety [19] and appear to be improving
general knowledge [20]. In our study, over 40% of the
women wished to use the Internet as an information
source, however research into it is lacking. Physicians
need to provide guidance on reliable Internet sources,
and encourage patients to discuss the information they
obtain. Care should also be taken to ensure that patients
who do not use the Internet have adequate access to
alternative information sources.
This study describes trends showing a need for
improved information about abnormal Pap smear results
in the wider European community. Nonetheless, it was
not powered for statistical comparisons and the study
design did not allow for statistical adjustment of results.
As a consequence, factors such as participant age and
marital status which differed between countries may
affect the interpretation of results. Further investigations
are needed to determine the impact of methods of com-
munication, patient age and background on women’s
feelings, as well as what are the most effective sources
of information, and how these factors differ between
countries. Development of questionnaires such as the
Process Outcome Specific Measure (POSM) question-
naire used in the TOMBOLA study will be important in
further research [21].
Few studies on the psychological consequences of
communication of abnormal Pap smear diagnoses in dif-
ferent countries are available. In this study, analysis of
the results by country showed variations in perceptions
and management of cervical cancer. Compared to
women in Spain and Portugal, French women consid-
ered themselves to be less well-informed, less well-sup-
ported, were more anxious, and less satisfied with the
level of information provided and the explanation of the
potential consequences of the illness. Internet and
Table 5 Information on treatment and consequences of the disease
Total
(N = 1475)
France
(N = 765)
A
Spain
(N = 467)
B
Portugal
(N = 243)
C
Patients felt well-informed about the...* Mean score (±SD)*
Disease 5.9 (3.2) 4.8 (3.0) 6.2 (3.4)
A 7.0 (2.8)
A
Treatments 5.9 (3.3) 4.6 (3.0) 6.1 (3.4)
A 7.0 (2.7)
AB
Emotional consequences 4.8 (3.2) 3.1 (2.7) 5.1 (3.5)
A 6.5 (2.8)
AB
Consequences on your relationship 5.0 (3.3) 3.4 (2.8) 5.4 (3.5)
A 6.3 (3.0)
AB
Consequences on your family life 4.9 (3.3) 3.1 (2.8) 5.2 (3.5)
A 6.5 (3.0)
AB
Consequences on your future as a mother (fertility) 5.2 (3.5) 3.6 (3.1) 5.4 (3.7)
A 6.6 (3.1)
AB
Information source used ** % patients
Doctor 79.6 67.4 85.4
A 85.9
A
Online 38.1 45.9
B 33.8 34.7
Media 14.6 23.1
BC 11.8 8.9
Friends 14.0 21.1
BC 10.5 10.3
Family 10.5 13.9
BC 7.2 10.3
Other 6.5 8.3 4.8 6.6
Potential best sources of information *** % patients
Doctor 79.0 77.0 72.7 87.4
AB
Web site 40.9 49.7
B 31.9 41.2
Newsletter 23.6 31.0
C 29.4
C 10.3
Media/TV 20.0 27.6
B 7.6 24.8
B
Women’s group 9.7 9.8 11.3 7.9
Other 1.4 1.6 1.6 0.9
Data from Questions 12, 13, 15
Superscript letters (A, B, C) show significantly superiority (0.1% risk) relative to the corresponding value in the indicated superscript column.
* Scale from 1-10, where 1 is not at all informed and 10 is very well informed.
** Multiple responses possible.
*** Two responses possible.
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in other countries. This argues against a blanket com-
munication strategy when informing patients of an
abnormal Pap smear result, suggesting instead that
information and management should be adapted on a
country-specific basis.
Conclusion
The study results confirm that psychological support
when communicating an abnormal Pap smear result
needs to be better managed to reduce women’sa n x i e t y .
The predominant feeling of worry reported on receipt of
an abnormal result and during follow-up, along with a
clearly expressed wish for information on cervical cancer
screening, show that there is room for improvement.
Dissemination of accurate information to the general
public is needed. Internet was ranked as an important
information source, highlighting the need to guarantee
the quality of this tool. Country differences suggest that
policies should be tailored to different cultures.
Additional material
Additional file 1: WACC Questionnaire. Copy of the WACC
Questionnaire distributed to participants
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